Reducing compliance costs in the
life sciences industry

Heat sterilization

Steam heating: High-temperature moist steam is the most widely used and dependable sterilization process as it is relatively economical, nontoxic, fast acting on microorganisms, and offers adequate penetration. On certain materials there can be some downsides, including corrosion and overheating.

Dry heating: Used where the material could be damaged by high temperature or impenetrable by moist steam (e.g. powders, petroleum products, and sharp instruments). Dry heat is nontoxic, low cost, penetrates materials and is noncorrosive for metal and sharp instruments. Penetration and microbicidal action is generally slower than steam. Some machines are equipped with forced-air or mechanical convection systems that circulate air at a higher velocity and can reduce process time.

Gas and liquid chemical sterilization

Sterilization with gas is subject to risks of explosion and issues with gas toxicity. Common types are shown below:

• Ethylene oxide gas (ETO, EtO, EO) is typically used to treat items that are moisture or heat-sensitive. Performance qualification of the ETO sterilization process is complex because in addition to temperature, the humidity, vacuum/positive pressure, and gas concentration also require rigid control
• Chlorine dioxide gas has been shown to be effective at decontamination of large-scale facilities, rooms, isolators, processing vessels and tanks, and biological safety cabinets
• Vaporized hydrogen peroxide has been used as a chemical sterilant for many years. This method is currently being used in aseptic product filling isolators, sterility testing isolators, lyophilizers, and sanitization of clean rooms
• Vaporized peracetic acid systems are not currently cleared for use by the FDA

Eurotherm solution:

• Distributed control system with configuration lock
• Fast acting control accuracy and process repeatability
• Functions for monitoring sterilization processes, including F₀ calculation for parametric release
• Functions for calculating MKT (mean kinetic temperature) and steam flow
• Batch/recipe management
• Data management based on ALCOA+ principles
• Power control for electric heaters
• Local HMIs to full SCADA solutions
• High availability architecture (redundant solutions and ‘Store and Forward’ feature)
• Data analysis
• AVEVA™ Historian
• Reporting

FDA 21 CFR part 11 and EU EudraLex Annex 11 regulations compliancy

As an automation and information technology leader our solutions meet the Electronic Record and Electronic Signature requirements as defined by the US and EU regulatory bodies.

Insight on sterilization by heat as regulated by EudraLex GMP guidelines Annex 1 – Final release vs Preliminary document proposal

The official release is less prescriptive than the preliminary proposal.

The initial version indicated a more robust and easier way to guarantee the effectiveness of the sterilization cycle through the complete separation of control and monitoring.

The latest released requirement does not prevent to combine control and monitoring, provided that ‘safeguards’ are demonstrated. Still, the example in brackets seems to refer to the preliminary draft suggesting the use of ‘duplex/double probes connected to independent control and monitoring systems.’

Eurotherm subject matter experts suggest to keep control and monitoring separated. This approach could allow avoiding GMP qualification (GAMP Cat 4 or 5) for the control component, being that resolved by the monitoring (GAMP Cat 3) element. This method is similar to that advised by ISPE guidance when it suggests considering the segregation of building management systems (BMS) and environmental monitoring systems (EMS).

Choosing a redundant monitoring solution (e.g. T2750 PAC) equipped with serial communication for data transfer from monitoring to control, can reduce the need for sensor duplication thus lowering costs for calibration and reducing errors and alarm occurrences.

Data Integrity ALCOA+ guidelines

To make sound decisions, you need to trust your data. Key regulatory bodies (FDA, EMA, WHO) and some advisory bodies (PIC/S, ISPE) have agreed on the Data Integrity related ALCOA+ concept. ALCOA+ defines that data should be Attributable, Legible, Contemporaneous, Original, and Accurate + Complete, Consistent, Enduring, and Available. As an experienced solution supplier, well established in life science processes, Eurotherm is a main supporter of that vision and contributed to the definition and the revision of some of these guidelines.

A 21st century risk-based approach

Business investments should be future-proof and audits hassle free. Eurotherm has developed and widely applied a set of good engineering practice (GEP) qualification documents based on ISPE GAMP 5 guidelines to assist with achieving these goals. Qualification documents can be maintained in electronic format. Industry is progressing from manual standard operating procedure (SOP) based manufacturing operations to a digitalized paperless quality systems approach based on FDA and ICH guidelines.

Quality by design

In a quality by design (QbD) approach, product quality is continuously monitored and controlled at the earliest stages, rather than waiting for a process to end. Pharmaceutical manufacturers need to focus on identifying, controlling, and validating process variables that could cause a non-compliant result. This is accomplished by managing the quality target product profile (QTPP), the critical quality attributes (CQA), and the critical process parameters (CPP). As defined by the process analytical technology (PAT) approach, Eurotherm can assist with measurement and performance analytics on CQAs and help manage CPP deviations, providing time-stamped evidence for correlation of parameter behaviors at their occurrence.

Pharma 4.0 ready technology

Eurotherm control and data recording solutions are EcoStruxure-ready, providing a Data Integrity layer within the Schneider Electric EcoStruxureTM platform. EcoStruxure is Schneider’s open IoT-enabled system architecture aiding the digital transformation to Pharma 4.0 technology.